Additionally, FCGR2A is significantly overexpressed in various cancers and associated with poor prognosis, such as clear cell renal cell carcinoma,45 malignant glioma46 and oesophageal squamous cell carcinoma.47 Here, FCGR2A is linked to clear cell renal carcinoma.